The following are licensed in the UK for the management of obesity:
Rationale:
Orlistat is licensed in the UK for the management of obesity. This medication works by inhibiting the absorption of dietary fats, thereby promoting weight loss effectively when combined with a reduced-calorie diet and exercise.
B: Sibutramine This appetite suppressant was withdrawn from the market due to safety concerns, specifically cardiovascular risks, making it unsuitable for obesity management in the UK.
C: Thiazide diuretics Primarily used to treat hypertension, thiazide diuretics do not address obesity directly and can lead to weight gain due to fluid retention, which detracts from weight loss efforts.
D: Pizotifen Though indicated for migraine prevention, pizotifen is not approved for obesity management and may actually contribute to weight gain, making it inappropriate for this purpose.
Sucralfate:
Rationale:
Sucralfate is effective in healing gastric ulcers. This medication forms a protective barrier on the ulcer site, facilitating healing by preventing further irritation and allowing the tissues to repair effectively.
A: Requires systemic absorption for anti-ulcer activity. Sucralfate acts locally at the ulcer site, meaning it does not need to be absorbed into the bloodstream to exert its therapeutic effects.
B: Contains aluminium. While sucralfate does contain aluminium, this characteristic does not determine its primary function or effectiveness in healing gastric ulcers, which is its main therapeutic role.
D: Is contraindicated in pregnancy. Sucralfate can be used during pregnancy when necessary, as its local action minimizes systemic exposure, making it generally considered safe under medical supervision.
Ranitidine is mostly given by intravenous infusion for the following indication.
Rationale:
Ranitidine is mostly given by intravenous infusion for the prophylaxis of gastric erosion in patients with extensive burns.
The use of ranitidine intravenously is primarily indicated for patients with extensive burns due to their increased risk of gastric erosion, which can lead to complications. This route allows for rapid absorption and immediate therapeutic effects, making it crucial in a hospital setting where these patients require careful management.
A: Rapid relief of gastric ulcer pain. While ranitidine may help alleviate gastric ulcer pain, it is not specifically administered via intravenous infusion for immediate relief in this scenario.
C: Zollinger Ellison syndrome. Although ranitidine can be used to manage this condition, intravenous infusion is not the primary method of administration for this particular indication.
D: Reflux oesophagitis. Ranitidine can treat reflux oesophagitis, but oral formulations are typically preferred over intravenous infusion for effective management in most cases.
Castor oil is classified as which type of laxative?
Rationale:
Castor oil is classified as an irritant laxative. Irritant laxatives stimulate bowel contractions and increase peristalsis, promoting movement in the intestines. Castor oil specifically induces rapid bowel activity, effectively relieving constipation.
A: Lubricating laxative This type of laxative works by coating the stool and intestines, which is not the primary action of castor oil, as it stimulates rather than lubricates.
B: Anthraquinone laxative Anthraquinone laxatives are derived from natural sources and function by increasing intestinal motility, differing from castor oil’s unique irritant mechanism that directly stimulates the bowel.
D: Stool softening laxative Stool softeners primarily add moisture to stool, easing passage. Castor oil does not soften stool in this manner; its primary function is to provoke bowel contractions.
In ulcerative colitis:
Rationale:
Intravenous hydrocortisone is of proven value in the treatment of acute colitis. This option is valid as intravenous hydrocortisone effectively reduces inflammation during severe exacerbations, providing rapid symptom relief and improving patient outcomes in acute ulcerative colitis cases.
B: Oral corticosteroids are first line for maintenance treatment. Maintenance therapy typically focuses on other agents rather than oral corticosteroids, which are primarily utilized for acute exacerbations rather than long-term management.
C: Localized rectal disease often responds to prednisolone enemas/suppositories. While rectal treatments exist, they are not universally effective for all patients, and they do not address more extensive disease involvement adequately.
D: In severe colitis codeine should be used. Codeine, an opioid, can worsen colonic dilation and toxicity in severe colitis, making its use inappropriate and potentially harmful in such acute situations.
Omeprazole enhances the effects of the following drugs through inhibition of drug metabolism:
Rationale:
D: Warfarin Omeprazole enhances Warfarin's effects by inhibiting its metabolism, leading to increased plasma levels. This interaction can heighten the anticoagulant effects, necessitating careful monitoring of INR levels to prevent bleeding complications.
A: Atenolol Atenolol's metabolism is primarily handled by the liver via different pathways than those affected by Omeprazole, rendering no significant interaction that would alter Atenolol's effectiveness or concentration in the body.
B: Amoxicillin Amoxicillin, being an antibiotic, is not significantly influenced by Omeprazole's metabolic inhibition, as it undergoes different metabolic processes that do not involve the same pathways impacted by Omeprazole.
C: Captopril Captopril is mainly excreted unchanged by the kidneys, and its metabolism is not notably affected by Omeprazole, resulting in no substantial increase in its effects or concentrations.
Which one of the following drugs is NOT a laxative agent?
Rationale:
Diphenoxylate is not a laxative agent. This medication functions primarily as an antidiarrheal, working to slow down gut movement, thus reducing the frequency of bowel movements rather than promoting them.
A: Methyl cellulose This substance is a bulk-forming laxative that absorbs water in the intestines, helping to create a softer stool and facilitate bowel movements.
C: Liquid paraffin Acting as a lubricant laxative, liquid paraffin helps ease stool passage by coating the bowel and softening the stool, making it easier to expel.
D: Lactulose This synthetic sugar serves as an osmotic laxative, drawing water into the intestines to soften stools and stimulate bowel movements effectively.
On your way to an examination you experience that vulnerable feeling that an attack of diarrhea is imminent. If you stopped at a drugstore, you could buy this antidiarrheal drug without a prescription even though it is related chemically to the strong opioid - analgesic meperidine
Rationale:
C: Loperamide is an over-the-counter antidiarrheal medication that effectively slows down gut movement, providing relief from diarrhea. Its chemical relation to meperidine allows it to function without prescription requirements.
A: Aluminum hydroxide primarily acts as an antacid, neutralizing stomach acid rather than addressing diarrhea. Its mechanism does not involve slowing intestinal transit, making it unsuitable for this condition.
B: Diphenoxylate is an antidiarrheal that requires a prescription due to its opioid characteristics, which can lead to misuse. It is not available over-the-counter, limiting accessibility during emergencies.
D: Magnesium hydroxide serves as a laxative and antacid, promoting bowel movements rather than alleviating diarrhea. Its primary function does not align with treating symptoms of diarrhea effectively.
Antacids administered concurrently reduce efficacy of the following antipeptic ulcer drug.
Rationale:
Antacids administered concurrently reduce the efficacy of sucralfate.
Sucralfate acts as a protective barrier in the stomach, but its effectiveness diminishes when taken with antacids, which alter the pH and affect its ability to adhere to ulcer sites.
A: Cimetidine Cimetidine is an H2 receptor antagonist that does not significantly interact with antacids, maintaining its effectiveness in reducing stomach acid secretion and promoting healing.
B: Omeprazole Omeprazole, a proton pump inhibitor, is not affected by antacids in the same way, as it works by irreversibly inhibiting acid production rather than relying on a protective mechanism.
D: Pirenzepine Pirenzepine selectively reduces gastric acid secretion without interference from antacids, allowing it to function effectively in managing peptic ulcers without compromising its action.
A 55-year-old woman with insulin-dependent diabetes of 40 years' duration complains of severe bloating and abdominal distress, especially after meals. Evaluation is consistent with diabetic gastroparesis. The prokinetic drug you would be most likely to recommend is
Rationale:
Metoclopramide is the most appropriate prokinetic drug to recommend for diabetic gastroparesis due to its ability to enhance gastrointestinal motility and alleviate symptoms of bloating and abdominal distress.
A: Granisetron. This medication primarily functions as an antiemetic and does not address the underlying motility issues associated with diabetic gastroparesis, thus failing to relieve abdominal discomfort.
B: Cimetidine. As an H2 antagonist, cimetidine reduces gastric acid secretion but has no impact on gastrointestinal motility, making it unsuitable for treating gastroparesis symptoms.
C: Droperidol. While droperidol is an antiemetic and can reduce nausea, its effects on gastric motility are not significant enough to treat the symptoms of diabetic gastroparesis effectively.
Ranitidine produces which of the following:
Rationale:
Ranitidine produces blockade of H2-receptors. This is accurate as ranitidine functions primarily as an H2 antagonist, inhibiting the action of histamine on H2 receptors in the stomach lining, thus reducing gastric acid secretion.
A: Blockade of M1-receptors Targeting M1 receptors relates to cholinergic signaling, which is unrelated to ranitidine's mechanism focused on histamine and gastric acid suppression specifically.
B: Blockade of H1-receptors H1 receptors are associated with allergic responses and not directly involved in gastric acid secretion, thus not relevant to ranitidine's therapeutic effects in acid reduction.
D: Acid neutralization Ranitidine primarily decreases acid production rather than neutralizing existing acid, distinguishing it from antacids, which directly interact with gastric acid to neutralize it.
Saline laxatives containing magnesium
Rationale:
Saline laxatives containing magnesium are more effective when administered on an empty stomach. This timing maximizes their osmotic effect, leading to enhanced bowel movement facilitation by increasing fluid in the intestines, which is crucial for effective constipation relief.
A: Reduce the secretion of cholecystokinin. Saline laxatives do not primarily influence cholecystokinin levels; their mechanism focuses on promoting intestinal water retention and bowel motility rather than hormonal secretion.
C: Are commonly used in the treatment in functional constipation. While saline laxatives can aid in constipation, they are not the first-line treatment for functional constipation, which often involves other therapeutic strategies.
D: Are safe in patients with impaired renal function. Magnesium can accumulate in patients with renal impairment, posing risks such as hypermagnesemia, thus caution is advised when prescribing these laxatives in such populations.
Most weak acid drugs as well as weak base drugs are absorbed primarily from the small intestine after oral administration because
Rationale:
Drugs are primarily absorbed from the small intestine due to its greater surface area compared to other parts of the gut. This increased surface area facilitates more extensive drug absorption, enhancing bioavailability.
A: Both types are more ionized in the small intestine. Ionization levels of weak acids and bases vary depending on pH, not necessarily leading to more absorption in the small intestine.
B: Both types are less ionized in the small intestine. While ionization can influence absorption, the primary factor for drug uptake is the surface area, not the ionization state.
C: The blood flow is greater in the small intestine than that of other parts of the gut. Although blood flow is crucial for absorption, it is the surface area that primarily determines absorption efficiency.
Ondansetron is a
Rationale:
Ondansetron is an antiemetic for cancer chemotherapy. This medication effectively alleviates nausea and vomiting associated with chemotherapy, enhancing patient comfort and adherence to treatment regimens, thereby improving overall outcomes in cancer care.
A: Second generation antihistaminic This classification does not apply to ondansetron, as it specifically targets serotonin receptors to prevent nausea rather than histamine receptors associated with allergic reactions.
B: Drug for peptic ulcer Ondansetron does not focus on treating peptic ulcers. Its mechanism is aimed at controlling nausea, not addressing gastric acid secretion or ulcer healing.
C: New antiarrhythmic Ondansetron's primary function is not related to heart rhythm management. It is specifically designed to address nausea and vomiting, not to influence cardiac conditions.
A patient undergoing cancer chemotherapy gets ondansetron for prophylaxis of drug-induced nausea and vomiting. Which of the following best describes this drug's main mechanism of action in this setting?
Rationale:
Blocks central serotonin (5-HT3) receptors. Ondansetron primarily functions by antagonizing 5-HT3 receptors in the central nervous system, preventing the binding of serotonin that triggers nausea and vomiting, particularly during chemotherapy.
A: Activates μ-type opioid receptors in the chemoreceptor trigger zone. This mechanism does not align with ondansetron's action, as it specifically targets serotonin receptors rather than opioid pathways associated with nausea control.
C: Blocks dopamine receptors. Ondansetron does not target dopamine receptors; its efficacy lies in serotonin receptor antagonism, making this option irrelevant for its mechanism in preventing chemotherapy-induced nausea.
D: Blocks histamine H1 receptors in the brainstem and inner ear. Ondansetron's action does not involve histamine receptors, which are more relevant to motion sickness and allergies, rather than chemotherapy-induced nausea and vomiting.
Which of the following purgatives undergoes enterohepatic circulation to produce prolonged action?
Rationale:
Phenolphthalein undergoes enterohepatic circulation to produce prolonged action. This process allows the compound to be reabsorbed into the bloodstream after being metabolized in the liver, extending its laxative effects over time.
A: Docusates This option primarily acts as a surfactant, facilitating stool softening, but does not engage in enterohepatic circulation for prolonged action.
C: Castor oil Although effective, castor oil acts quickly and does not participate in enterohepatic circulation to enhance its duration of action.
D: Lactulose This osmotic agent promotes bowel movement through water retention but lacks enterohepatic circulation for sustained effectiveness.
The following purgative interferes with absorption of fat soluble vitamins:
Rationale:
Liquid paraffin interferes with the absorption of fat-soluble vitamins. This is due to its ability to coat the intestinal lining, preventing the uptake of essential nutrients like vitamins A, D, E, and K, thus impairing their absorption and leading to deficiencies when used as a purgative.
B: Methyl cellulose This substance acts as a bulk-forming laxative and does not affect the absorption of fat-soluble vitamins, as it primarily facilitates bowel movements through water retention.
C: Magnesium sulphate Known for its osmotic properties, magnesium sulphate draws water into the intestines to induce bowel movements, without impacting the absorption of fat-soluble vitamins significantly.
D: Lactulose This synthetic sugar serves as a laxative by increasing water content in the colon, but it does not hinder the absorption of fat-soluble vitamins in the digestive tract.
Which of the following statements concerning traveler's diarrhea (TD) is true?
Rationale:
Traveler's diarrhea can usually be avoided by not eating raw vegetables, seafood, or eggs when traveling to third-world countries.
This option emphasizes the significance of cautious dietary choices to mitigate the risk of infection, as these food items are often contaminated with pathogens causing TD. Awareness of food safety is crucial for travelers in regions with less rigorous health standards.
B: TD can be prevented by taking one dose of antibiotic 1 day before a trip. This approach lacks evidence supporting its efficacy in preventing TD, as antibiotics are not recommended for prophylaxis.
C: A specific of Helicobacter pylori is the primary pathogen responsible for TD. While H. pylori is linked to gastric issues, it is not the predominant cause of traveler's diarrhea, which is often viral or bacterial.
D: Phillip's milk of magnesia is used to prevent/treat TD. This medication is primarily an antacid and laxative, not an established treatment or prevention method for traveler's diarrhea.
What is true of acid control therapy with Hâ‚‚ blockers?
Rationale:
Hâ‚‚ blockers generally heal duodenal ulcers faster than gastric ulcers. This is due to their ability to significantly reduce gastric acid secretion, promoting a more favorable environment for the healing of duodenal mucosa compared to gastric tissue.
B: It checks bleeding in case of bleeding peptic ulcer. Hâ‚‚ blockers primarily reduce acid secretion, which does not directly address bleeding management in peptic ulcers effectively.
C: It prevents gastroesophageal reflux. While Hâ‚‚ blockers may alleviate some symptoms, they do not entirely prevent gastroesophageal reflux, as they primarily focus on acid secretion reduction rather than reflux control.
D: Both (a) and (b). Although option A is valid, option B does not accurately represent the primary function of Hâ‚‚ blockers, making this combination incorrect.
A 55-year-old woman with insulin-dependent diabetes of 40 years' duration complains of severe bloating and abdominal distress, especially after meals. Evaluation is consistent with diabetic gastroparesis. The drug you would be most likely to recommend is
Rationale:
Metoclopramide is the most appropriate recommendation for this patient. It effectively increases gastric motility and alleviates symptoms associated with diabetic gastroparesis, making it suitable for managing her severe bloating and distress.
A: Docusate serves primarily as a stool softener and does not address the underlying gastric motility issues associated with gastroparesis, thus failing to alleviate her abdominal discomfort.
B: Dopamine is actually contraindicated in gastroparesis management, as it can inhibit gastric emptying and worsen the patient's symptoms rather than providing the necessary relief from bloating.
C: Loperamide primarily functions as an anti-diarrheal medication, which does not target the delayed gastric emptying characteristic of gastroparesis, leaving the patient's abdominal distress unaddressed.
The following drugs cause constipation:
Rationale:
A: Amitriptyline is known to cause constipation as a common side effect due to its anticholinergic properties, which slow down gastrointestinal motility and disrupt normal bowel function.
A: Amiodarone does not typically affect bowel function, as its primary uses are related to heart rhythm management, not gastrointestinal side effects.
C: Amoxicillin primarily targets bacterial infections and does not have constipation as a known side effect; rather, it often leads to gastrointestinal disturbances such as diarrhea.
D: Misoprostol is used to prevent ulcers and induce labor, and while it may cause diarrhea, it does not contribute to constipation in patients who use it.
Misoprostol
Rationale:
Misoprostol is helpful in preventing ulcers induced by NSAIDs. This medication protects the stomach lining and reduces the risk of ulcers by increasing mucus and bicarbonate secretion, making it effective for patients taking nonsteroidal anti-inflammatory drugs.
B: Can cause constipation. Misoprostol primarily acts on the gastrointestinal tract to prevent ulcers, not to induce constipation, which is a side effect of other medications, not this one.
C: Does not inhibit acid secretion. Misoprostol actually does help in protecting the stomach by promoting mucus production, which indirectly aids in managing acid levels rather than inhibiting them outright.
D: Can delay labor in a pregnant woman. Misoprostol is used to induce labor, not delay it, as it stimulates uterine contractions and is often utilized for cervical ripening.
The most dependable emetic used to expel ingested poisons is
Rationale:
C: Intramuscular apomorphine is the most dependable emetic used to expel ingested poisons due to its rapid onset and effectiveness in inducing vomiting, making it suitable for emergency situations involving toxic substances.
A: Intramuscular emetine lacks the rapid action and reliability of apomorphine, resulting in delayed efficacy in cases of poisoning.
B: Oral syrup ipecacuanha is less favored today due to safety concerns and variable effectiveness, making it a less reliable choice compared to apomorphine.
D: Oral bromocriptine is primarily used for other medical conditions and does not serve as a reliable emetic for poison expulsion, limiting its application in emergencies.
Which risk factor is most likely to predispose patient to the complications of peptic ulcer disease?
Rationale:
Helicobacter pylori infection significantly predisposes individuals to complications of peptic ulcer disease, as it directly contributes to ulcer formation and exacerbates symptoms, leading to increased risks of bleeding and perforation.
A: Obesity does not have a direct causal relationship with peptic ulcer complications; rather, its effects are more related to overall health than specific ulcer pathophysiology.
B: Race does not inherently influence the development or complications of peptic ulcers, as genetic and environmental factors play a more substantial role in ulcerogenesis.
C: Age can contribute to the risk of peptic ulcer complications, but it is not as directly linked to ulcer formation as the presence of Helicobacter pylori infection.
In peptic ulcer, antacids are now primarily used for
Rationale:
Antacids are now primarily used for prompt pain relief. Antacids neutralize stomach acid, providing quick alleviation from the discomfort associated with peptic ulcers, allowing patients to manage acute pain effectively while other treatments address the underlying condition.
B: Ulcer healing Antacids do not promote the healing of ulcers; their primary function is to relieve symptoms rather than facilitate the actual restoration of the gastric lining.
C: Preventing ulcer relapse Antacids are not designed to prevent future occurrences of ulcers; they primarily focus on alleviating immediate symptoms rather than addressing long-term prevention strategies.
D: Control of bleeding from the ulcer Antacids do not have any role in controlling bleeding; they primarily target pain relief rather than managing severe complications associated with peptic ulcers.
Antacids:
Rationale:
Antacids: Magnesium salts tend to cause diarrhoea. Magnesium-based antacids can have a laxative effect, which is a well-documented side effect due to their ability to draw water into the intestines, thus promoting bowel movements.
A: Large doses heal gastric ulcers more frequently than duodenal ulcers. Healing rates for ulcers depend on various factors, and dosage alone does not determine the frequency of healing between ulcer types.
B: Standard doses reduce gastric acidity for approximately 4 hours. While antacids do reduce acidity, their effects can vary significantly based on individual metabolism and the specific formulation used, not just duration.
D: Aluminium salts tend to cause a diuresis. Aluminium salts are more commonly associated with constipation rather than diuresis, as they can bind to phosphate in the gut, affecting fluid balance differently.
All of the following are used in treatment of diarrhea EXCEPT:
Rationale:
Neostigmine. This option is primarily a medication used for conditions like myasthenia gravis and does not function as a treatment for diarrhea, which requires agents that target gastrointestinal fluid balance or motility.
A: Kaolin. This substance is an absorbent clay that helps to bulk up stool and reduce the frequency of diarrhea, making it a viable treatment option.
C: Oral rehydration solution. This solution is crucial for replenishing lost fluids and electrolytes during diarrhea, effectively addressing dehydration associated with this condition.
D: Loperamide. As an antidiarrheal agent, loperamide works by slowing gut motility, thereby reducing the frequency of bowel movements, making it effective in diarrhea management.
We have two patients; one requires suppression of emesis caused by an anticancer drug. Another patient has severe diabetic gastroparesis and gastroesophageal reflux, which requires relief. Which drug would be most suitable for both indications?
Rationale:
Metoclopramide is the most suitable drug for both indications. It effectively suppresses emesis associated with anticancer treatments while also enhancing gastric motility, providing relief for diabetic gastroparesis and gastroesophageal reflux.
A: Diphenoxylate primarily serves as an antidiarrheal agent, lacking efficacy in managing emesis or enhancing gastric motility, thus unsuitable for the patients' conditions.
B: Aprepitant is specifically designed to prevent nausea and vomiting due to chemotherapy, but it does not address gastric motility issues related to diabetic gastroparesis or reflux.
C: Pyridoxine, or vitamin B6, is mainly used for conditions like nausea in pregnancy but does not offer therapeutic benefits for either emesis or gastric motility disorders.
Drugs useful to control vomiting include the following EXCEPT:
Rationale:
Drugs useful to control vomiting include the following EXCEPT: Apomorphine.
Apomorphine primarily acts as an emetic, inducing vomiting rather than controlling it, which distinguishes it from the other listed medications that are specifically designed to suppress nausea and vomiting effectively.
A: Chlorpromazine This medication possesses antiemetic properties, effectively reducing nausea and vomiting through its action on dopamine receptors.
B: Domperidone As a dopamine antagonist, Domperidone effectively alleviates nausea and vomiting by enhancing gastric motility and inhibiting central emetic pathways.
C: Ondansetron This selective serotonin receptor antagonist is highly effective in preventing nausea and vomiting, particularly in chemotherapy and postoperative settings, making it a reliable option for management.
Which of the following statements about adsorbent drugs used for diarrhea is true?
Rationale:
B: Very safe because not absorbed systemically. Adsorbent drugs, such as kaolin and pectin, primarily function within the gastrointestinal tract, effectively binding toxins and preventing systemic absorption, thereby minimizing potential side effects.
A: Useful for treatment of severe diarrhea. While adsorbent drugs can assist in mild cases, they are not the first-line treatment for severe diarrhea, where rehydration is crucial.
C: In general, small doses are needed to relieve diarrhea. Effective relief often requires specific dosing tailored to individual cases; small doses may not adequately address the severity of symptoms.
D: Kaolin and pectin are considered to be very effective (category I) adsorbents. Though commonly used, their effectiveness can vary, and they may not always be classified as top-tier treatments for diarrhea.
The following are licensed in the UK for the management of obesity:
Rationale:
Orlistat
Orlistat is a licensed medication in the UK for obesity management, as it effectively inhibits fat absorption in the intestines, helping individuals achieve weight loss when combined with a reduced-calorie diet.
B: Sibutramine
Sibutramine has been withdrawn from the UK market due to safety concerns related to cardiovascular risks, rendering it unsuitable for obesity management.
C: Thiazide diuretics
Thiazide diuretics primarily treat hypertension and fluid retention, lacking efficacy in weight management and not being licensed for obesity treatment in the UK.
D: Pizotifen
Pizotifen is an antihistamine used for migraine prevention, not indicated for obesity management, and therefore does not fit the criteria for licensed obesity treatments in the UK.
Sucralfate:
Rationale:
Sucralfate is effective in healing gastric ulcers. This medication works by forming a protective barrier over ulcer sites, enhancing healing and providing relief from symptoms associated with gastric ulcers, thereby promoting recovery.
A: Requires systemic absorption for anti-ulcer activity. Sucralfate exerts its effects locally at the ulcer site and does not require absorption into the bloodstream to function effectively.
B: Contains aluminium. While sucralfate does contain aluminium, this aspect does not directly relate to its primary function of promoting ulcer healing and protecting the gastric lining.
D: Is contraindicated in pregnancy. Sucralfate is generally considered safe during pregnancy, as it acts locally in the gastrointestinal tract without systemic absorption, minimizing risks to the developing fetus.
Ranitidine is mostly given by intravenous infusion for the following indication.
Rationale:
B: Prophylaxis of gastric erosion in patients with extensive burns. Ranitidine is particularly effective for preventing gastric erosions in burn patients due to stress-induced mucosal disease, making intravenous infusion a suitable route for rapid onset and continuous delivery.
A: Rapid relief of gastric ulcer pain. While ranitidine can alleviate ulcer pain, it is not primarily used for immediate relief but rather for long-term management and prevention.
C: Zollinger Ellison syndrome. Although ranitidine can reduce acid secretion, it is not the first-line treatment for this syndrome, where more potent medications like proton pump inhibitors are preferred.
D: Reflux oesophagitis. Ranitidine may provide some symptomatic relief for reflux oesophagitis, but it is not the primary indication for intravenous administration, which is better suited for burn patients.
Castor oil is classified as which type of laxative?
Rationale:
Castor oil is classified as an irritant laxative. Irritant laxatives stimulate the intestinal walls, leading to increased peristalsis and facilitating bowel movements, which is the primary action of castor oil in alleviating constipation.
A: Lubricating laxative Lubricating laxatives coat the stool to ease its passage, differing fundamentally from castor oil’s stimulating mechanism. Castor oil does not primarily function through lubrication.
B: Anthraquinone laxative Anthraquinone laxatives derive from natural sources and promote bowel movements through a different biochemical pathway. Castor oil does not contain anthraquinones and operates via irritation instead.
D: Stool softening laxative Stool softening laxatives work by increasing water absorption in the stool, leading to softer consistency. Castor oil does not primarily act by softening but by irritating the intestines.
In ulcerative colitis:
Rationale:
Intravenous hydrocortisone is of proven value in the treatment of acute colitis. This option is supported by clinical evidence demonstrating that intravenous hydrocortisone effectively reduces inflammation and manages severe exacerbations of ulcerative colitis, providing rapid relief during acute episodes.
B: Oral corticosteroids are first line for maintenance treatment. Although oral corticosteroids may be used for flare-ups, they are not ideal for long-term management due to potential side effects.
C: Localized rectal disease often responds to prednisolone enemas/suppositories. While rectal treatments may be beneficial, they are not proven to be as effective as intravenous hydrocortisone in acute situations.
D: In severe colitis codeine should be used. Codeine is contraindicated in severe colitis as it can slow intestinal motility, potentially worsening the condition and leading to further complications.
Omeprazole enhances the effects of the following drugs through inhibition of drug metabolism:
Rationale:
Omeprazole enhances the effects of Warfarin through inhibition of drug metabolism. This interaction occurs as omeprazole can reduce the metabolic clearance of warfarin, leading to increased plasma concentrations and heightened anticoagulant effects.
A: Atenolol Atenolol is primarily metabolized by the liver enzyme CYP2D6, which is not significantly affected by omeprazole, thus maintaining its expected blood levels and therapeutic effects.
B: Amoxicillin Amoxicillin is excreted unchanged by the kidneys and does not rely on liver metabolism, rendering omeprazole's inhibitory effect irrelevant to this antibiotic's efficacy.
C: Captopril Captopril undergoes renal clearance and is not significantly influenced by omeprazole, which primarily affects drugs that are metabolized by liver enzymes rather than impacting renal pathways.
Which one of the following drugs is NOT a laxative agent?
Rationale:
Diphenoxylate is not a laxative agent. It functions primarily as an antidiarrheal medication, reducing bowel movements and helping to manage diarrhea rather than promoting bowel movements as laxatives do.
A: Methyl cellulose promotes bowel movements by increasing stool bulk and hydration, making it a fiber-based laxative that aids in relieving constipation effectively.
C: Liquid paraffin acts as a lubricant laxative, easing stool passage by coating the intestinal walls and preventing water absorption, which helps alleviate constipation symptoms.
D: Lactulose is a synthetic sugar that draws water into the bowel, increasing stool moisture and volume, thereby functioning as an osmotic laxative to relieve constipation efficiently.
On your way to an examination you experience that vulnerable feeling that an attack of diarrhea is imminent. If you stopped at a drugstore, you could buy this antidiarrheal drug without a prescription even though it is related chemically to the strong opioid - analgesic meperidine
Rationale:
C: Loperamide is a non-prescription antidiarrheal medication that effectively decreases intestinal motility, providing relief from diarrhea. Its chemical relation to meperidine highlights its efficacy without the narcotic side effects typically associated with opioids.
A: Aluminum hydroxide primarily serves as an antacid, neutralizing stomach acid rather than addressing diarrhea directly, making it unsuitable for this specific situation requiring immediate antidiarrheal action.
B: Diphenoxylate, while an antidiarrheal, is a controlled substance requiring a prescription due to its potential for abuse and its opioid-like properties, which limits its availability without medical oversight.
D: Magnesium hydroxide acts as a laxative rather than an antidiarrheal. Its primary function is to draw water into the intestines, potentially worsening diarrhea rather than alleviating it.
Antacids administered concurrently reduce efficacy of the following antipeptic ulcer drug.
Rationale:
Antacids administered concurrently reduce the efficacy of sucralfate.
Sucralfate requires an acidic environment to activate its protective mechanism on the gastric lining, and antacids neutralize stomach acid, thereby diminishing sucralfate’s therapeutic effect and ability to form a protective barrier.
A: Cimetidine Cimetidine functions as an H2 receptor antagonist, not dependent on stomach acidity for its action, thus remaining effective despite the presence of antacids in the gastrointestinal tract.
B: Omeprazole Omeprazole is a proton pump inhibitor that directly inhibits acid production, making it less susceptible to interactions with antacids, which do not influence its mechanism of action.
D: Pirenzepine Pirenzepine is a selective M1 muscarinic antagonist that reduces gastric acid secretion and does not interact with antacids, maintaining its pharmacological effectiveness regardless of acid presence.
A 55-year-old woman with insulin-dependent diabetes of 40 years' duration complains of severe bloating and abdominal distress, especially after meals. Evaluation is consistent with diabetic gastroparesis. The prokinetic drug you would be most likely to recommend is
Rationale:
Metoclopramide is the most appropriate prokinetic drug for treating diabetic gastroparesis in this patient. It enhances gastrointestinal motility and accelerates gastric emptying, alleviating symptoms like bloating and abdominal distress effectively.
A: Granisetron primarily acts as an antiemetic and does not have prokinetic properties needed to treat gastroparesis symptoms. Its effectiveness is limited to nausea and vomiting management.
B: Cimetidine functions as a histamine H2 receptor antagonist and is primarily used for reducing gastric acid secretion. It does not address gastrointestinal motility issues associated with gastroparesis.
C: Droperidol is an antipsychotic and antiemetic agent that may help with nausea but does not significantly improve gastric motility or address the underlying issues in diabetic gastroparesis.
Ranitidine produces which of the following:
Rationale:
Ranitidine produces blockade of H2-receptors. This antihistamine selectively inhibits H2 receptors in the stomach lining, leading to reduced gastric acid secretion and providing relief from conditions like peptic ulcers and gastroesophageal reflux disease.
A: Blockade of M1-receptors. This option pertains to muscarinic receptors, which are not directly affected by ranitidine, focusing instead on cholinergic pathways unrelated to gastric acid production.
B: Blockade of H1-receptors. This involves histamine receptors linked to allergic responses and inflammation, which are not relevant to ranitidine's mechanism of action concerning gastric acid secretion.
D: Acid neutralization. While this term refers to reducing acidity, ranitidine does not neutralize existing acid; rather, it prevents its production by blocking H2 receptors in the stomach.
Saline laxatives containing magnesium
Rationale:
Saline laxatives containing magnesium are more effective when administered on an empty stomach. Administering these laxatives without food enhances their absorption and promotes quicker bowel movement, making them particularly beneficial for acute constipation relief. This efficacy is crucial for patients needing immediate results from their laxative treatment.
A: Reduce the secretion of cholecystokinin. This option misrepresents the action of saline laxatives, which primarily function to draw water into the intestines rather than influencing digestive hormone secretion.
C: Are commonly used in the treatment of functional constipation. Although saline laxatives may be utilized, they are not the first-line treatment for functional constipation, which often involves dietary changes and fiber supplements.
D: Are safe in patients with impaired renal function. This choice overlooks the potential risks associated with magnesium accumulation in individuals with renal impairment, which can lead to serious complications, including hypermagnesemia.
Most weak acid drugs as well as weak base drugs are absorbed primarily from the small intestine after oral administration because
Rationale:
Most weak acid drugs as well as weak base drugs are absorbed primarily from the small intestine after oral administration because the surface area of the small intestine is greater than other parts of the gut.
The extensive surface area of the small intestine facilitates a higher absorption capacity for both weak acid and weak base drugs, enhancing their bioavailability post-ingestion.
A: Both types are more ionized in the small intestine. Ionization levels vary based on pH, and weak acids and bases do not uniformly exhibit increased ionization in the small intestine.
B: Both types are less ionized in the small intestine. While weak bases may be less ionized, weak acids do not share this trait uniformly, affecting absorption dynamics.
C: The blood flow is greater in the small intestine than that of other parts of the gut. Enhanced blood flow aids absorption but is not the primary factor in drug uptake compared to surface area.
Ondansetron is a
Rationale:
Ondansetron is an antiemetic for cancer chemotherapy. This medication effectively prevents nausea and vomiting associated with chemotherapy treatments, making it crucial for improving the quality of life in cancer patients undergoing these therapies. Its targeted action on serotonin receptors enhances its efficacy in managing these distressing side effects.
A: Second generation antihistaminic Lacks the specific action needed for nausea and vomiting prevention, as ondansetron primarily functions through serotonin receptor antagonism, which is not characteristic of antihistamines.
B: Drug for peptic ulcer Ondansetron does not address peptic ulcer conditions, focusing instead on mitigating nausea and vomiting induced by chemotherapy rather than treating gastrointestinal ulcers directly.
C: New antiarrhythmic This classification is misleading; ondansetron does not have any role in cardiac rhythm management, as its pharmacological purpose revolves entirely around preventing nausea and vomiting.
A patient undergoing cancer chemotherapy gets ondansetron for prophylaxis of drug-induced nausea and vomiting. Which of the following best describes this drug's main mechanism of action in this setting?
Rationale:
Blocks central serotonin (5-HT3) receptors. Ondansetron primarily functions by inhibiting 5-HT3 receptors in the central nervous system, effectively preventing nausea and vomiting induced by chemotherapy agents, thus providing significant relief to patients.
A: Activates μ-type opioid receptors in the chemoreceptor trigger zone. This option describes a mechanism that would promote nausea rather than prevent it, making it unsuitable for managing chemotherapy-induced symptoms.
C: Blocks dopamine receptors. While dopamine antagonism is relevant for certain antiemetics, ondansetron specifically targets serotonin receptors, rendering this explanation irrelevant to its primary action in the context of chemotherapy.
D: Blocks histamine H1 receptors in the brainstem and inner ear. This mechanism relates to motion sickness and allergies, not to the serotonin-driven nausea associated with chemotherapy, highlighting a mismatch in therapeutic application.
Which of the following purgatives undergoes enterohepatic circulation to produce prolonged action?
Rationale:
Phenolphthalein undergoes enterohepatic circulation to produce prolonged action. This compound is reabsorbed in the intestine and circulated back to the liver, enhancing its effects and duration of action in the gastrointestinal tract, making it effective for bowel movement regulation.
A: Docusates Lack enterohepatic circulation, primarily acting as surfactants to soften stool rather than extending their effects through liver recycling, thus providing a shorter duration of action.
C: Castor oil Functions as a stimulant laxative, promoting bowel movements through irritation of the intestinal lining, but does not engage in enterohepatic circulation for prolonged effects.
D: Lactulose Serves as an osmotic laxative, drawing water into the bowel to soften stool. It does not participate in enterohepatic circulation, limiting its action duration.
The following purgative interferes with absorption of fat soluble vitamins:
Rationale:
Liquid paraffin interferes with absorption of fat soluble vitamins. This purgative coats the intestinal walls, creating a barrier that inhibits the uptake of essential vitamins like A, D, E, and K, leading to potential deficiencies.
B: Methyl cellulose This compound primarily acts as a bulk-forming agent and does not create barriers that significantly impact the absorption of fat-soluble vitamins in the digestive system.
C: Magnesium sulphate While serving as an osmotic laxative, it facilitates fluid retention in the intestines but does not obstruct the absorption processes of fat-soluble vitamins.
D: Lactulose This synthetic sugar primarily treats constipation by drawing water into the colon, having no direct impact on the absorption of fat-soluble vitamins in the digestive tract.
Which of the following statements concerning traveler's diarrhea (TD) is true?
Rationale:
TD can usually be avoided by not eating raw vegetables, seafood or eggs when traveling to third-world countries. This strategy reduces exposure to potential pathogens commonly found in contaminated food sources prevalent in those regions, effectively minimizing the risk of gastrointestinal infections associated with traveler's diarrhea.
B: TD can be prevented by taking one dose of antibiotic 1 day before a trip. Antibiotic prophylaxis is not universally effective and may lead to resistance or other adverse effects.
C: A specific of Helicobacter pylori is the primary pathogen responsible for TD. While Helicobacter pylori is associated with certain gastrointestinal issues, it is not the main cause of traveler's diarrhea.
D: Phillip's milk of magnesia is used to prevent/treat TD. This medication primarily serves as an antacid and laxative, lacking efficacy in preventing or treating traveler's diarrhea specifically.
What is true of acid control therapy with Hâ‚‚ blockers?
Rationale:
Hâ‚‚ blockers generally heal duodenal ulcers faster than gastric ulcers. This is attributed to their ability to reduce stomach acid, promoting a more favorable healing environment specifically for duodenal ulceration.
B: It checks bleeding in case of bleeding peptic ulcer. While Hâ‚‚ blockers reduce acid secretion, they are not primarily designed to control bleeding in peptic ulcers.
C: It prevents gastroesophageal reflux. Hâ‚‚ blockers may alleviate symptoms but do not provide complete prevention of gastroesophageal reflux disease, which often requires additional treatment approaches.
D: Both (a) and (b). Although option A holds true, option B does not align with the primary function of Hâ‚‚ blockers, negating the correctness of this combined choice.
A 55-year-old woman with insulin-dependent diabetes of 40 years' duration complains of severe bloating and abdominal distress, especially after meals. Evaluation is consistent with diabetic gastroparesis. The drug you would be most likely to recommend is
Rationale:
Metoclopramide is the most suitable recommendation for managing diabetic gastroparesis. This medication enhances gastric motility and accelerates gastric emptying, effectively alleviating symptoms like bloating and abdominal distress in patients with diabetes.
A: Docusate A stool softener, docusate does not address the underlying motility issues associated with gastroparesis and is primarily used for constipation relief, making it unsuitable for this condition.
B: Dopamine As a neurotransmitter, dopamine could potentially worsen gastroparesis symptoms by inhibiting gastric motility, which is counterproductive for a patient experiencing severe bloating and abdominal distress.
C: Loperamide This anti-diarrheal medication slows intestinal movement, which would exacerbate the symptoms of gastroparesis by further delaying gastric emptying, thereby worsening abdominal discomfort after meals.
The following drugs cause constipation:
Rationale:
A: Amiodarone This medication primarily affects cardiovascular function and is not associated with gastrointestinal side effects like constipation, focusing instead on heart rhythm management.
B: Amitriptyline Amitriptyline is a tricyclic antidepressant that significantly impacts the gastrointestinal system, leading to decreased motility and increased likelihood of constipation as a notable side effect.
C: Amoxicillin This antibiotic targets bacterial infections and does not typically interfere with bowel function, often resulting in diarrhea instead, as it can disrupt normal gut flora.
D: Misoprostol This medication is primarily used to prevent stomach ulcers and induce labor. It usually promotes gastrointestinal motility and is more associated with diarrhea than constipation.
Misoprostol
Rationale:
Misoprostol is helpful in preventing ulcers induced by NSAIDs. This medication serves as a prostaglandin analog, effectively protecting the gastric mucosa from damage caused by non-steroidal anti-inflammatory drugs, thereby reducing ulcer formation.
B: Can cause constipation. While some medications may induce constipation, misoprostol primarily acts to prevent ulcers and is more commonly associated with gastrointestinal side effects like diarrhea.
C: Does not inhibit acid secretion. Misoprostol is known to have a multifaceted role, including reducing gastric acid secretion, contrary to this statement, which misrepresents its pharmacological effects.
D: Can delay labor in a pregnant woman. Misoprostol is often used to induce labor and facilitate uterine contractions, making this option misleading regarding its actual functionality in pregnancy management.
The most dependable emetic used to expel ingested poisons is
Rationale:
C: Intramuscular apomorphine is the most dependable emetic used to expel ingested poisons. It acts rapidly and effectively stimulates the vomiting center in the brain, making it a preferred choice in emergency situations.
A: Intramuscular emetine lacks the same level of reliability and speed compared to apomorphine, making it less effective for immediate poison expulsion in urgent scenarios.
B: Oral syrup ipecacuanha has fallen out of favor due to inconsistent efficacy and potential complications, rendering it a less reliable option for inducing vomiting in poisoning cases.
D: Oral bromocriptine is primarily used for conditions like Parkinson's disease and does not serve as an effective emetic, failing to meet the requirements for poison expulsion.
Which risk factor is most likely to predispose patient to the complications of peptic ulcer disease?
Rationale:
Helicobacter pylori infection is the risk factor most likely to predispose patients to complications of peptic ulcer disease. This bacterium is a primary cause of ulcers, leading to inflammation, ulcer formation, and potential complications such as bleeding and perforation, significantly impacting patient health and requiring targeted treatment.
A: Obesity does influence overall health but is not a direct causative factor in the development of peptic ulcers or their complications.
B: Race may affect the prevalence of certain diseases, but it does not specifically predispose individuals to the complications associated with peptic ulcer disease.
C: Age can be a contributing factor to various health issues; however, it lacks the direct link seen with Helicobacter pylori infection in causing peptic ulcer complications.
In peptic ulcer, antacids are now primarily used for
Rationale:
Antacids are now primarily used for prompt pain relief. Their primary function is to neutralize stomach acid quickly, providing immediate comfort to patients experiencing pain associated with peptic ulcers, thus alleviating discomfort effectively.
B: Ulcer healing Antacids do not address the underlying causes of ulcers or promote tissue repair, making them unsuitable for the healing process which requires more targeted treatments.
C: Preventing ulcer relapse Antacids do not have a preventative role in ulcer relapse; they primarily focus on immediate symptom relief rather than long-term management of ulcer recurrence.
D: Control of bleeding from the ulcer Antacids have no effect on bleeding control; rather, they simply alleviate pain and discomfort, leaving bleeding management to other specific medical interventions.
Antacids:
Rationale:
C: Magnesium salts tend to cause diarrhoea. Magnesium-based antacids are known for their laxative effects, leading to increased bowel movements, which can result in diarrhea, particularly when consumed in larger quantities.
A: Large doses heal gastric ulcers more frequently than duodenal ulcers. Healing rates are not determined by the type of ulcer but rather by other factors like medication type and patient health.
B: Standard doses reduce gastric acidity for approximately 4 hours. The duration of action for standard doses of antacids can vary, often lasting longer than four hours based on individual metabolism.
D: Aluminium salts tend to cause a diuresis. Aluminium salts typically may lead to constipation rather than diuresis, countering the expected outcome related to fluid excretion and overall urinary output.
All of the following are used in treatment of diarrhea EXCEPT:
Rationale:
Neostigmine is not used in the treatment of diarrhea. It primarily functions as a medication that inhibits the breakdown of acetylcholine, affecting muscle contractions and not addressing the underlying causes or symptoms of diarrhea.
A: Kaolin assists in treating diarrhea by adsorbing toxins and pathogens, thus reducing gastrointestinal irritation and slowing down bowel movements effectively.
C: Oral rehydration solution is crucial in managing diarrhea by replenishing lost fluids and electrolytes, preventing dehydration and maintaining hydration levels during gastrointestinal disturbances.
D: Loperamide effectively reduces diarrhea by slowing down gut motility, increasing transit time, and enhancing stool consistency, making it a standard treatment for this condition.
We have two patients; one requires suppression of emesis caused by an anticancer drug. Another patient has severe diabetic gastroparesis and gastroesophageal reflux, which requires relief. Which drug would be most suitable for both indications?
Rationale:
Metoclopramide is the most suitable drug for both indications. It effectively suppresses emesis associated with anticancer treatments and alleviates symptoms of diabetic gastroparesis and gastroesophageal reflux, acting as a prokinetic agent.
A: Diphenoxylate primarily addresses diarrhea and lacks efficacy in treating nausea or gastrointestinal motility disorders, making it unsuitable for emesis or gastroparesis relief.
B: Aprepitant is specifically designed to prevent chemotherapy-induced nausea and vomiting but does not address the motility issues associated with diabetic gastroparesis or gastroesophageal reflux.
C: Pyridoxine is primarily used for vitamin B6 deficiency and nausea during pregnancy, failing to provide the necessary gastrointestinal motility support required for both patients' conditions.
Drugs useful to control vomiting include the following EXCEPT:
Rationale:
Drugs useful to control vomiting include the following EXCEPT apomorphine. Apomorphine acts primarily as an emetic agent, inducing vomiting rather than preventing it, thereby making it unsuitable for controlling nausea.
A: Chlorpromazine This antipsychotic drug possesses antiemetic properties, effectively suppressing nausea and vomiting through its dopamine receptor antagonism in the central nervous system.
B: Domperidone As a dopamine receptor antagonist, domperidone effectively alleviates nausea and vomiting by enhancing gastrointestinal motility and blocking dopamine effects in the chemoreceptor trigger zone.
C: Ondansetron This selective serotonin 5-HT3 receptor antagonist is widely recognized for its efficacy in preventing and treating nausea and vomiting, particularly in chemotherapy-induced cases.
Which of the following statements about adsorbent drugs used for diarrhea is true?
Rationale:
Very safe because not absorbed systemically. This characteristic of adsorbent drugs allows them to act locally in the gastrointestinal tract, providing relief from diarrhea without entering the bloodstream, thus ensuring minimal side effects.
A: Useful for treatment of severe diarrhea. Adsorbent drugs are primarily intended for mild to moderate diarrhea, lacking sufficient efficacy for managing severe cases effectively.
C: In general, small doses are needed to relieve diarrhea. Typically, adsorbent drugs require larger doses to achieve the desired therapeutic effect, not just small quantities.
D: Kaolin and pectin are considered to be very effective (category I) adsorbents. While these substances are used, they do not consistently meet the criteria for high effectiveness across all cases of diarrhea.